UAE EDE Medical Device Registration Guide (2026): Complete Process After MOHAP Transition

The UAE's Regulatory Transformation: From MOHAP to EDE

On January 2, 2025, Federal Decree-Law No. 38 of 2024 came into force, establishing the Emirates Drug Establishment (EDE) as the UAE's federal authority responsible for regulating medical products — including medical devices and IVDs. By early 2026, the EDE assumed full responsibility for 44 core regulatory services previously managed by the Ministry of Health and Prevention (MOHAP), consolidating life sciences oversight under a single, specialized authority.

For medical device manufacturers, this transition is consequential. The EDE now manages product registration, renewal, variations, pharmacovigilance, import permits, and post-market compliance — all through its digital portal at www.ede.gov.ae. MOHAP retains jurisdiction over community and compounding pharmacies and jointly manages certain administrative functions with EDE, but device registration is firmly in EDE's hands.

The UAE medical devices market was valued at approximately $3.18 billion in 2025 and is projected to reach $4.71 billion by 2032, growing at a CAGR of 5.8%. With 100% foreign ownership permitted in free zones like Dubai Healthcare City (DHCC) and a strategic geographic position serving as a gateway to the broader MENA region, the UAE represents a high-priority market for medical device manufacturers worldwide.

This guide covers the complete registration process under the EDE framework, including classification, fees, documentation requirements, timelines, and the practical differences between Dubai (DHA) and Abu Dhabi (DOH).

EDE Regulatory Structure & Scope

What the EDE Oversees

The EDE's medical device mandate covers:

• Product registration and marketing authorization for all medical devices and IVDs
• Establishment licensing for manufacturers, warehouses, medical stores, and marketing offices
• Pharmacovigilance and adverse event reporting
• Import permits for registered and unregistered devices
• Variations and renewals of existing registrations
• Post-market surveillance and compliance enforcement
• Clinical study accreditation for medical device trials
• Export certificates for devices manufactured in the UAE

What Remains with MOHAP

MOHAP retains jurisdiction over:

• Community and compounding pharmacies
• Certain administrative licensing functions (jointly managed)
• Health advertising approvals (jointly with EDE)
• Emergency and psychotropic medicine regulation
• Complaint handling related to pharmaceutical facilities

The February 2026 Anti-Monopoly Mechanism

In February 2026, the EDE introduced a landmark policy requiring companies to appoint more than one agent for each medical product distributed in the UAE. This breaks the previous single-distributor monopoly model and is mandated under Federal Decree-Law No. 38 of 2024. Manufacturers entering the UAE market should plan their distribution strategy around this requirement from the outset.

UAE Medical Device Classification System

The UAE follows the Global Harmonization Task Force (GHTF) classification framework, using a four-class risk-based system for medical devices:

For IVD devices, the classification uses a separate four-tier system:

Classification is based on the device's intended use, duration of patient contact, and degree of invasiveness. If you already hold CE marking under the EU MDR or FDA clearance, your classification will generally correspond — but the EDE reserves the right to reclassify devices. Manufacturers unsure of their classification can request an official classification letter from the EDE for a fee of 500 AED.

Practical tip: If you have EU MDR CE marking, Class I generally corresponds to UAE Class I, IIa to Class II, IIb to Class III, and III to Class IV. However, software and combination products may be classified differently. Confirm classification before beginning the registration process.

Step-by-Step Registration Process

Step 1: Appoint a Local Authorized Representative (LAR)

All foreign manufacturers must appoint a UAE-based Local Authorized Representative (LAR), also called a Marketing Authorization Holder (MAH). This entity:

• Submits registration applications on your behalf through the EDE portal
• Holds the marketing authorization certificate
• Manages all regulatory communications with the EDE
• Maintains post-market surveillance records
• Is responsible for vigilance reporting and recall coordination

The LAR must be licensed by the EDE as a pharmaceutical establishment (warehouse, medical store, or marketing office). Free zone entities can also serve as LARs.

Step 2: Register the Manufacturing Site

Before submitting product applications, the manufacturing facility must be registered with the EDE. This requires:

• ISO 13485 certificate (current and valid)
• Manufacturing license from the country of origin
• Site master file or facility documentation
• GMP compliance evidence

Site registration takes approximately 14–28 working days (realistically 4–8 weeks) and carries a fee of 100 AED application + 10,000 AED processing fee (total: 10,100 AED) for first-time registration, according to the EDE's official service portal. Site renewal fees are identical (100 AED + 10,000 AED).

Step 3: Confirm Device Classification

Submit a classification request through the EDE portal if classification is uncertain. The EDE will issue an official classification letter within 10–14 business days. Fee: 500 AED per classification request.

Step 4: Prepare the Registration Dossier

The technical dossier must include:

Administrative Documents:

• Completed application form (via EDE portal)
• Authorization letter to the LAR (legalized)
• ISO 13485 certificate of the manufacturer
• Certificate of Free Sale (CFS) from the country of origin
• Declaration of Conformity (DoC)
• CE certificate or FDA clearance (if applicable — not required but strengthens the application)

Technical Documents:

• Device description and intended use
• Risk classification rationale
• Essential principles checklist (GHTF/IMDRF format)
• Technical file or summary technical documentation (STED)
• Clinical evaluation report or clinical data
• Labeling and Instructions for Use (IFU) — Arabic mandatory, English alongside Arabic

Quality and Safety:

• Biocompatibility reports (if applicable)
• Sterilization validation (for sterile devices)
• Electrical safety and electromagnetic compatibility (IEC 60601 series for active devices)
• Software documentation (IEC 62304, if applicable)
• Pharmacovigilance commitment letter

Step 5: Submit via the EDE Portal

The LAR logs into the EDE portal using UAE PASS authentication and submits the complete dossier electronically. Payment is made via the portal's e-payment system:

• Application fee: 100 AED (paid at submission)
• Registration fee: 5,000 AED (paid upon approval)

Step 6: Technical Committee Review

The EDE's technical committee reviews the application. The published review timeline is 45 working days. In practice, timelines vary:

Delays typically result from incomplete documentation, missing legalized documents, or requests for supplementary clinical data. The committee may issue deficiency letters requiring response within 60 working days.

Step 7: Obtain Registration Certificate

Upon approval, the EDE issues a Medical Device Marketing Authorization valid for 5 years from the date of committee approval. The registered device is listed in the EDE's database and can be imported, marketed, and sold throughout the UAE.

Fee Summary

Note: Government fees are per product or product family. Total investment including documentation preparation, authentication, translation, and local representative fees typically ranges from $15,000 to $50,000+ depending on product complexity.

DHA Dubai vs DOH Abu Dhabi: Understanding the Difference

A common source of confusion is the relationship between federal registration (EDE) and local health authorities. Here is the critical distinction:

Federal vs. Local Authority Roles

Key point: Medical device registration in the UAE is a federal process managed by the EDE. Once a device is registered with the EDE, it can be marketed throughout the entire UAE — including Dubai and Abu Dhabi. Neither DHA nor DOH registers medical devices separately. Their role is limited to licensing healthcare facilities and professionals within their respective emirates.

However, there are practical differences in how devices enter the supply chain:

• Dubai (DHA): Healthcare facilities licensed by DHA procure devices through registered distributors. DHA does not maintain a separate device registry but may require evidence of EDE registration during facility inspections and procurement processes. Dubai Healthcare City (DHCC), a free zone, offers 100% foreign ownership and has its own licensing authority (DHCR) for healthcare operators — but device registration remains federal through EDE.

• Abu Dhabi (DOH): Similarly, DOH-licensed facilities require EDE-registered devices. Abu Dhabi's procurement processes, particularly for public hospitals under SEHA (now part of ADNOC Medical Services), may impose additional vendor qualification requirements beyond EDE registration.

• Northern Emirates (MOHAP): Healthcare facilities in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah are licensed by MOHAP but use EDE-registered devices.

Renewal Process

Registrations are valid for 5 years. The renewal process requires:

1. Initiate renewal at least 3 months before expiry — the LAR submits through the EDE portal
2. Submit updated documentation:
   • Updated ISO 13485 certificate
   • Updated Certificate of Free Sale
   • Updated Declaration of Conformity
   • Post-market surveillance reports (mandatory for Class III/IV)
   • List of countries where the device is marketed
   • Samples (if requested, typically 3 physical samples with certificates of analysis)
3. Pay renewal fees: 100 AED application + 2,500 AED registration renewal
4. Timeline: 2–4 weeks for straightforward renewals; up to 8 weeks for Class III/IV renewals requiring additional compliance evidence

For significant variations (design changes, new indications, manufacturing site changes), a separate variation application with fees of approximately 10,000 AED applies.

Post-Market Surveillance Under EDE

The EDE has strengthened post-market requirements since taking over from MOHAP:

• High-risk devices (Class III/IV): Biannual Periodic Safety Update Reports (PSURs) required
• Adverse event reporting: Significant adverse events must be reported within defined timelines (generally 10–30 days depending on severity)
• Field Safety Corrective Actions (FSCA): Must be reported to EDE before implementation
• Import monitoring: The EDE's digital tracking system is being enhanced throughout 2026 for automated compliance monitoring
• Pharmacovigilance: Centralized under EDE with dedicated pharmacovigilance officer requirements for establishments

IVD-Specific Requirements

IVD devices follow the same general registration process but with additional considerations:

• Classification follows the IVD-specific A-D system
• Performance evaluation data is required (aligned with EU IVDR or FDA requirements)
• Point-of-care testing devices may require additional evidence of usability in non-laboratory settings
• Companion diagnostics must demonstrate clinical utility and analytical/clinical performance
• IVD reagents must include stability data and lot-to-lot consistency evidence

The UAE IVD market is projected to reach $574 million by 2030, growing at 5.2% CAGR.

Practical Recommendations

1. Start early. Despite the 45-working-day published timeline, first-time registrations realistically take 6–12 months from project initiation to certificate issuance, especially for Class III/IV devices.

2. Choose your LAR carefully. The LAR holds your marketing authorization. Switching representatives is possible but administratively burdensome. With the new anti-monopoly rules requiring multiple agents, plan your distribution network strategically.

3. Leverage reference market approvals. While CE marking or FDA clearance is not a substitute for EDE registration, it significantly strengthens the application and may reduce the depth of technical review.

4. Budget realistically. Government fees are modest (~16,100 AED for first-time entry), but total project costs including LAR fees, documentation preparation, legalization, translation, and consulting support typically range from $15,000 to $50,000+.

5. Prepare Arabic documentation early. All labeling and IFUs must include Arabic. Arabic must have equal prominence alongside English. Start translation and layout work well before submission.

6. Monitor the EDE portal. The transition from MOHAP is still being refined. Some links may redirect between portals, and document requirements may be updated. Check the EDE portal regularly and maintain communication with your LAR.